LIVE/VIRTUAL ACTIVITIES
Bio Ascend – Designing CME Solutions For a Virtual World, Our Live and Virtual CME Activities Are Designed to Keep HCPs Educated.
Bio Ascend helps healthcare providers (HCPs) like you stay educated by providing the CME resources you need for continuing education. Our vast selection of activities is devoted entirely to solid tumor and hematologic malignancies – with engaging options in both in-person and virtual environments. Activities feature leading experts discussing the latest data and how to apply it to clinical practice, providing you with critical insight and direction on how to incorporate therapeutic advancements into your practice.
Satellite Symposia:
Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies
August 11, 2021 – Live/Virtual
Time: 1:00 PM – 3:00 PM HST (4 PM PT/6 PM CT/7 PM ET)
This live symposium on The Treatment of Patients with Hematologic Malignancies will be presented at #PPLC21 and feature expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma.
Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.
| Agenda | |
|---|---|
|
7:00PM |
Welcome, Introductions, and Pre-session Survey |
|
7:10PM |
Overview of CAR T-cell Therapy
|
|
7:25PM |
Clinical experience with CAR T-cell therapy for lymphoma and myeloma
|
|
7:55PM |
How to manage novel AE profiles
|
|
8:20PM |
Practical aspects of CAR T-cell therapy
|
|
8:40PM |
Panel Discussion and Audience Q&A |
|
8:50PM |
Recap of Key Points and Post-Session Survey |
|
9:00PM |
Program Adjourns |
Symposium Chair
Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris
Professor Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Faculty
Tara Graff, DO, MS
Mission Cancer and Blood
Des Moines, Iowa
Nina Shah, MD
Associate Professor, Department of Medicine
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California
Satellite Symposia:
Current and Emerging CAR T-Cell and Other Cellular Therapies for the Treatment of Patients with Hematologic Malignancies
August 11, 2021 – Live/Virtual
Time: 1:00 PM – 3:00 PM HST (4 PM PT/6 PM CT/7 PM ET)
This live symposium on The Treatment of Patients with Hematologic Malignancies will be presented at #PPLC21 and feature expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma.
Be sure to check back in September to view the CME-certified Expert Insights recording with two of the symposium faculty who will provide a summarization of the symposium’s take-home messages most relevant to practice and clinical decision making.
Symposium Chair
Julie M. Vose, MD, MBA
Neumann M. and Mildred E. Harris
Professor Chief, Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska
Faculty
Tara Graff, DO, MS
Mission Cancer and Blood
Des Moines, Iowa
Nina Shah, MD
Associate Professor, Department of Medicine
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California
| Agenda | |
|---|---|
|
7:00PM |
Welcome, Introductions, and Pre-session Survey |
|
7:10PM |
Overview of CAR T-cell Therapy
|
|
7:25PM |
Clinical experience with CAR T-cell therapy for lymphoma and myeloma
|
|
7:55PM |
How to manage novel AE profiles
|
|
8:20PM |
Practical aspects of CAR T-cell therapy
|
|
8:40PM |
Panel Discussion and Audience Q&A |
|
8:50PM |
Recap of Key Points and Post-Session Survey |
|
9:00PM |
Program Adjourns |
